Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOAO L DE QUEVEDO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1205231008
CMS profile
1286765
Location
HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$5,177.81

13 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $4,641.00 6
ITI, Inc. $121.88 1
Sunovion Pharmaceuticals Inc. $102.54 1
Alkermes, Inc. $97.68 1
Neurocrine Biosciences, Inc. $95.70 1
Otsuka America Pharmaceutical, Inc. $92.56 1
Merck Sharp & Dohme LLC $26.45 2

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOAO L DE QUEVEDO

NPI 1205231008 · CMS profile ID 1286765

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry

HOUSTON, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1205231008?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOAO L DE QUEVEDO, NPI 1205231008, CMS profile ID 1286765. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1205231008?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). JOAO L DE QUEVEDO, NPI 1205231008, CMS profile ID 1286765. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1205231008?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
JOAO L DE QUEVEDO, NPI 1205231008, CMS profile ID 1286765, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–13 of 13 matching records. This page contains 13 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1205231008?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

13 matching records · $5,177.81 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 13 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–13 of 13.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Alkermes, Inc. $97.6812/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 925836137 CMS
ITI, Inc. $121.8812/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945670999 CMS
Merck Sharp & Dohme LLC $11.9911/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944493391 CMS
Otsuka America Pharmaceutical, Inc. $92.5611/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 929277937 CMS
ABBVIE INC. $86.3110/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890841965 CMS
Sunovion Pharmaceuticals Inc. $102.5409/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 921188679 CMS
Neurocrine Biosciences, Inc. $95.7008/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 963411063 CMS
ABBVIE INC. $2,250.0008/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890841961 CMS
ABBVIE INC. $18.7508/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890841963 CMS
ABBVIE INC. $19.8905/23/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890841955 CMS
ABBVIE INC. $2,250.0005/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890841957 CMS
ABBVIE INC. $16.0505/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890841959 CMS
Merck Sharp & Dohme LLC $14.4605/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944499607 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,533.11 45
PY2020 $10,739.65 15
PY2021 $2,950.79 10
PY2022 $5,177.81 13
PY2023 $30,607.97 81
PY2024 $2,867.32 56
PY2025 $2,214.39 55

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $198,539.00 282
PY2024 Principal investigator $93,685.00 73
PY2023 Principal investigator $269,170.50 100
PY2022 Principal investigator $195,711.52 29
PY2021 Principal investigator $63,472.50 14

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

100 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024621
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024641
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024659
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024677
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024693
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024711
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024727
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024747
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024761
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024781
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024797
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025131
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025149
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025167
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025183
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025205
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025221
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025241
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025257
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025271
Principal investigator 1 LivaNova USA, Inc. $65.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025287
Principal investigator 1 LivaNova USA, Inc. $2,405.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025305
Principal investigator 1 LivaNova USA, Inc. $1,586.00 12/27/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043025321
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024481
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024499
Principal investigator 1 LivaNova USA, Inc. $1,092.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024517
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024533
Principal investigator 1 LivaNova USA, Inc. $1,170.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024551
Principal investigator 1 LivaNova USA, Inc. $65.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024569
Principal investigator 1 LivaNova USA, Inc. $65.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024587
Principal investigator 1 LivaNova USA, Inc. $65.00 12/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024605
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023725
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023741
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023757
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023775
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023793
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023809
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023827
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023845
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023863
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023879
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023895
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023913
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023933
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023947
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023963
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023979
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043023995
Principal investigator 1 LivaNova USA, Inc. $1,170.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024011
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024027
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024041
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024057
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024075
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024093
Principal investigator 1 LivaNova USA, Inc. $1,092.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024111
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024127
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024143
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024163
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024181
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024199
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024215
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024235
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024251
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024271
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024287
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024305
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024319
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024335
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024353
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024375
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024391
Principal investigator 1 LivaNova USA, Inc. $162.50 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024409
Principal investigator 1 LivaNova USA, Inc. $65.00 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024427
Principal investigator 1 LivaNova USA, Inc. $227.50 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024445
Principal investigator 1 LivaNova USA, Inc. $227.50 11/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
RECOVER No dispute reported 06/30/2026 1043024463
Principal investigator 1 LivaNova USA, Inc. $325.00 10/17/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043069835
Principal investigator 1 LivaNova USA, Inc. $1,155.00 10/17/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043070061
Principal investigator 1 LivaNova USA, Inc. $695.00 10/17/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043070519
Principal investigator 1 LivaNova USA, Inc. $70.00 10/17/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043070981
Principal investigator 1 LivaNova USA, Inc. $1,417.00 09/06/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025655
Principal investigator 1 LivaNova USA, Inc. $6,103.50 09/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025639
Principal investigator 1 LivaNova USA, Inc. $6,565.00 08/17/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025619
Principal investigator 1 LivaNova USA, Inc. $395.00 08/15/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043069073
Principal investigator 1 LivaNova USA, Inc. $6,838.00 08/10/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025607
Principal investigator 1 LivaNova USA, Inc. $8,788.00 08/03/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025585
Principal investigator 1 LivaNova USA, Inc. $10,608.00 07/20/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025565
Principal investigator 1 LivaNova USA, Inc. $3,640.00 07/13/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025547
Principal investigator 1 LivaNova USA, Inc. $7,033.00 07/07/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025531
Principal investigator 1 LivaNova USA, Inc. $1,480.00 07/05/2023 Non-covered Recipient Entity
Advarra, Inc. (Central IRB)
The RECOVER sUb-study, which leverages quaNtitative and Credible research tOols from Verily, will providE assessment measuRes for depressive episodes (UNCOVER) No dispute reported 06/30/2026 1043069027
Principal investigator 1 LivaNova USA, Inc. $4,875.00 06/28/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025515
Principal investigator 1 LivaNova USA, Inc. $8,261.50 06/15/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025495
Principal investigator 1 LivaNova USA, Inc. $8,060.00 06/01/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025477
Principal investigator 1 LivaNova USA, Inc. $6,688.50 05/19/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025461
Principal investigator 1 LivaNova USA, Inc. $11,134.50 05/05/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025443
Principal investigator 1 LivaNova USA, Inc. $9,002.50 04/26/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025427
Principal investigator 1 LivaNova USA, Inc. $4,036.50 04/20/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025405
Principal investigator 1 LivaNova USA, Inc. $66,313.00 04/13/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025391
Principal investigator 1 LivaNova USA, Inc. $130.00 03/24/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025373
Principal investigator 1 LivaNova USA, Inc. $21,424.00 01/25/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025357
Principal investigator 1 LivaNova USA, Inc. $20,202.00 01/20/2023 Non-covered Recipient Entity
University of TX Health Science Ctr-Hou
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression (RECOVER) No dispute reported 06/30/2026 1043025340